151 related articles for article (PubMed ID: 8179860)
21. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
22. Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
de Bree R; Roos JC; Plaizier MA; Quak JJ; van Kamp GJ; den Hollander W; Snow GB; van Dongen GA
Br J Cancer; 1997; 75(7):1049-60. PubMed ID: 9083342
[TBL] [Abstract][Full Text] [Related]
23. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
[TBL] [Abstract][Full Text] [Related]
24. The feasibility of radioimmunotherapy of head and neck cancer.
Gerretsen M; Quak JJ; Brakenhoff RH; Snow GB; van Dongen GA
Eur J Cancer B Oral Oncol; 1994; 30B(2):82-7. PubMed ID: 8032305
[TBL] [Abstract][Full Text] [Related]
25. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
[TBL] [Abstract][Full Text] [Related]
26. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Périé S; Talbot JN; Monceaux G; Grahek D; Kerrou K; Montravers F; St Guily JL
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):755-60. PubMed ID: 10961809
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.
Colnot DR; Quak JJ; Roos JC; de Bree R; Wilhelm AJ; Snow GB; van Dongen GA
Head Neck; 2001 Jul; 23(7):559-65. PubMed ID: 11400244
[TBL] [Abstract][Full Text] [Related]
28. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
[TBL] [Abstract][Full Text] [Related]
29. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
30. [Bilateral lymph node metastases in the neck from uncertain primary in the nasal vestibulum].
Olszewski J; Miloński J
Otolaryngol Pol; 2007; 61(6):1011-3. PubMed ID: 18546954
[TBL] [Abstract][Full Text] [Related]
31. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
Chow E; Payne D; Keane T; Panzarella T; Izard MA
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
[TBL] [Abstract][Full Text] [Related]
32. [Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma].
Di B; Li XM; Zhang JJ; Liu S; Song Q; Tao ZF; Fan C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):485-90. PubMed ID: 27480295
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunodetection of head and neck cancer. A review.
Hopsu EV; Kairemo KJ
Acta Oncol; 1993; 32(7-8):735-40. PubMed ID: 8305220
[TBL] [Abstract][Full Text] [Related]
34. Distant lymphatic metastasis from head and neck cancer.
Alavi S; Namazie A; Sercarz JA; Wang MB; Blackwell KE
Ann Otol Rhinol Laryngol; 1999 Sep; 108(9):860-3. PubMed ID: 10527276
[TBL] [Abstract][Full Text] [Related]
35. [Computed tomography of cervical lymph node metastases in malignant tumors of the head and neck region].
Bähren W; Haase S; Lenz M; Ranzinger G; Wierschin W
Rofo; 1983 Sep; 139(3):281-4. PubMed ID: 6411547
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck.
Don DM; Anzai Y; Lufkin RB; Fu YS; Calcaterra TC
Laryngoscope; 1995 Jul; 105(7 Pt 1):669-74. PubMed ID: 7603268
[TBL] [Abstract][Full Text] [Related]
37. Head and neck cancer localization with indium labelled carcinoembryonic antigen: a pilot project.
Timon CI; McShane D; Hamilton D; Walsh MA
J Otolaryngol; 1991 Aug; 20(4):283-7. PubMed ID: 1920585
[TBL] [Abstract][Full Text] [Related]
38. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of FDG-PET in head-and-neck cancer with neck metastasis after definitive radiation treatment: in regard to Yao et al. (Int J Radiat Oncol Biol Phys 2005;63:991-999).
Wang TF; Tsai EL; Kao RH
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):633; author reply 633-4. PubMed ID: 16690448
[No Abstract] [Full Text] [Related]
40. Cystic metastasis from head and neck squamous cell cancer: a distinct disease variant?
Goldenberg D; Sciubba J; Koch WM
Head Neck; 2006 Jul; 28(7):633-8. PubMed ID: 16477605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
